Your browser doesn't support javascript.
loading
Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
Ishikawa, Masashi; Iwasa, Satoru; Nagashima, Kengo; Aoki, Masahiko; Imazeki, Hiroshi; Hirano, Hidekazu; Shoji, Hirokazu; Honma, Yoshitaka; Okita, Natsuko; Takashima, Atsuo; Kato, Ken; Saruta, Masayuki; Boku, Narikazu.
Afiliación
  • Ishikawa M; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. nightexpress@hotmail.com.
  • Iwasa S; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, 3-19-18, Nishishinbashi, Minato-ku, Tokyo, 105-8471, Japan. nightexpress@hotmail.com.
  • Nagashima K; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Aoki M; Research Center for Medical and Health Data Science, The Institute of Statistical Mathematics, 10-3, Midori-cho, Tachikawa, Tokyo, 190-8562, Japan.
  • Imazeki H; Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-0016, Japan.
  • Hirano H; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Shoji H; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Honma Y; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Okita N; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Takashima A; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Kato K; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Saruta M; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Boku N; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Invest New Drugs ; 38(2): 533-540, 2020 04.
Article en En | MEDLINE | ID: mdl-31264067
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Peritoneales / Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Albúminas / Anticuerpos Monoclonales Humanizados / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Peritoneales / Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Albúminas / Anticuerpos Monoclonales Humanizados / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2020 Tipo del documento: Article País de afiliación: Japón